- EpiPen maker CEO to seething lawmakers: We’re doing the world a favor http://arstechnica.com/science/2016/09/epipen-maker-ceo-to-seething-lawmakers-were-doing-the-world-a-favor/ 6 comments politics
Linking pages
- Feds go after Mylan for scamming Medicaid out of millions on EpiPen pricing | Ars Technica http://arstechnica.com/science/2016/09/feds-go-after-mylan-for-scamming-medicaid-out-of-millions-on-epipen-pricing/ 1459 comments
- CVS just announced a super cheap generic alternative to EpiPen | Ars Technica http://arstechnica.com/science/2017/01/cvs-just-announced-a-super-cheap-generic-alternative-to-epipen/ 102 comments
- Pharma company boosts the price of an old acne cream 3,900% | Ars Technica http://arstechnica.com/science/2016/09/got-acne-and-money-heres-a-possibly-effective-zit-cream-thats-now-10k/ 56 comments
- Lawsuit: Mylan’s epic EpiPen price hike wasn’t about greed—it’s worse | Ars Technica https://arstechnica.com/science/2017/04/lawsuit-mylans-epic-epipen-price-hike-wasnt-about-greed-its-worse/ 54 comments
- To keep EpiPen sales up, Mylan threatened states, sued making bogus claims | Ars Technica https://arstechnica.com/science/2017/04/mylan-bullied-sued-states-to-get-them-to-use-epipens-court-documents-show/ 37 comments
- Congress to Reddit: Preserve purported posts of Clinton’s e-mail admin | Ars Technica http://arstechnica.com/information-technology/2016/09/congress-to-reddit-preserve-purported-posts-of-clintons-e-mail-admin/ 12 comments
- Despite what Mylan said, its price hikes hit patients’ wallets hard | Ars Technica https://arstechnica.com/science/2017/03/despite-what-mylan-said-its-price-hikes-hit-patients-wallets-hard/ 10 comments
- Drug coupons are costing us billions: Lawmakers seek end to slimy scheme | Ars Technica https://arstechnica.com/science/2017/06/drug-coupons-are-costing-us-billions-lawmakers-seek-end-to-slimy-scheme/ 10 comments
- Mylan chairman: Drug pricing critics ought to go copulate with themselves | Ars Technica https://arstechnica.com/science/2017/06/mylan-chairman-drug-pricing-critics-ought-to-go-copulate-with-themselves/ 7 comments
- For ripping off Medicaid, EpiPen maker Mylan pays Feds $465 million | Ars Technica http://arstechnica.com/science/2016/10/for-ripping-off-medicaid-epipen-maker-mylan-pays-feds-465-million/ 6 comments
- With help of coal tax credits, Mylan had a negative 294-percent tax rate in 2016 | Ars Technica https://arstechnica.com/science/2017/06/with-help-of-coal-tax-credits-mylan-had-a-negative-294-percent-tax-rate-in-2016/ 3 comments
- Years after Mylan’s epic EpiPen price hikes, it finally gets a generic rival | Ars Technica https://arstechnica.com/science/2018/08/fda-approves-generic-version-of-mylans-600-epipens-but-the-price-is-tbd/ 0 comments
- Amid outrage and tumbling stocks, Mylan’s chairman pocketed $97M | Ars Technica https://arstechnica.com/science/2017/05/amid-outrage-and-tumbling-stocks-mylans-chairman-pocketed-97m/ 0 comments
Linked pages
- Rage mounts against pharma corp. that jacked cost of life-saving EpiPen by 400% | Ars Technica http://arstechnica.com/science/2016/08/rage-mounts-against-pharma-corp-that-jacked-cost-of-life-saving-epipen-by-400/ 197 comments
- Congress to Reddit: Preserve purported posts of Clinton’s e-mail admin | Ars Technica http://arstechnica.com/information-technology/2016/09/congress-to-reddit-preserve-purported-posts-of-clintons-e-mail-admin/ 12 comments
- Reviewing the Rising Price of EpiPens - Part 1 - YouTube https://www.youtube.com/watch?v=syQ0IpOekVI 3 comments
Related searches:
Search whole site: site:arstechnica.com
Search title: EpiPen maker CEO to seething lawmakers: We’re doing the world a favor | Ars Technica
See how to search.